Company Profile

Company Description

Esperion Therapeutics is a biopharmaceutical company focused on developing innovative therapies for patients with high unmet medical needs in cardiovascular and metabolic diseases. The company specializes in creating oral, small-molecule drugs designed to lower low-density lipoprotein cholesterol (LDL-C) levels, offering alternatives to traditional treatments. Their lead products target patients who struggle with statin intolerance or require additional LDL-C reduction. By leveraging cutting-edge research, the firm aims to address gaps in cardiovascular care, improving patient outcomes. Their work emphasizes accessibility, safety, and efficacy, positioning them as a key player in lipid management and preventive cardiology. The company collaborates with global partners to expand the reach of its therapies.